Grow Your Pharma Business Digitally
Market Place
Post Enquiry
Company
01 Novo Nordisk Canada Inc. (6)
Patent
01 2264243 (2)
02 2468374 (2)
03 2545034 (2)
Product
01 LIRAGLUTIDE (3)
02 Liraglutide (3)
Dosage
01 SOLUTION (3)
02 multi dose pen -injector (3)
Exp Date
01 2017-08-22 (4)
02 2024-11-18 (2)